mitochondrial dysfunction

Telomir Publishes Telomir-Zn AMD Preclinical Findings

MIAMI, Fla. — September 17, 2026 Telomir Pharmaceuticals announced the peer-reviewed publication of new preclinical research showing that Telomir-Zn...

By cGxPwire Editor
September 21, 2026

.Clinical

Eos SENOLYTIX Highlights PTC-2105 Preclinical Data at Obesity Forum

HOUSTON, Texas, June 5, 2026 Eos SENOLYTIX, Inc. presented new preclinical findings for its lead MitoXcel™ geropeptide candidate PTC-2105...

By cGxPwire Editor
June 6, 2026

.Clinical

Cirius Therapeutics Highlights CIR-0602K as Promising New Therapy for Type 2 Diabetes

GRAND RAPIDS, Mich., June 1, 2026 Cirius Therapeutics has announced the presentation of new clinical data supporting CIR-0602K, its...

By cGxPwire Editor
June 3, 2026

.Clinical

Khondrion Begins Phase II Trial of Sonlicromanol in Post-COVID Fatigue

NIJMEGEN, The Netherlands, May 19, 2026 Khondrion announced that the first patient has been dosed in the Phase II...

By cGxPwire Editor
May 19, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

mitochondrial dysfunction

Telomir Publishes Telomir-Zn AMD Preclinical Findings

Eos SENOLYTIX Highlights PTC-2105 Preclinical Data at Obesity Forum

Cirius Therapeutics Highlights CIR-0602K as Promising New Therapy for Type 2 Diabetes

Khondrion Begins Phase II Trial of Sonlicromanol in Post-COVID Fatigue